Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
The daily trading volume of the Chinese decentralized contract exchange Sun Wukong reached 86 million USDT, with liquidity depth increasing up to threefold.

The daily trading volume of the Chinese decentralized contract exchange Sun Wukong reached 86 million USDT, with liquidity depth increasing up to threefold.

ChaincatcherChaincatcher2025/10/19 07:37
Show original

ChainCatcher news, according to official social media sources, on October 17, the world's first Chinese decentralized contract exchange Sun Wukong once again set new records in various metrics. The number of new users in a single day exceeded 3,000, daily trading volume reached 86 million USDT, and daily new capital inflow amounted to 25 million USDT.

In addition, the platform's depth continues to improve: BTC's 0.1% depth increased by 330%, 0.5% depth increased by 288%, and 1% depth increased by 156%; ETH's 0.1% depth increased by 264%, 0.5% depth increased by 210%, and 1% depth increased by 150%.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11

Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential

According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.

智通财经2026/09/21 07:11

Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.

TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).

智通财经2026/09/21 07:11